MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection.

zapnometinib (ATR-002) - Atriva Therap

http://www.ncbi.nlm.nih.gov/pubmed/38979428

Annette B Vogel; Annika Schönsiegel; Julia Koch-Heier; Marina Ebensperger; Oliver Planz; Raphael S Zinser; Yvonne Füll

Jul 9, 2024